High plasma dp‐ucMGP level indicating a poor VitK status is a biomarker of kidney damage and cardiovascular risk in CKD patients. VitK2 supplementation may improve the carboxylation status of MGP. This evidence concerns the gene MGP and chronic kidney disease.